Medifast Q1 revenue falls as active coach count drops

Medifast

04/05/2026 21:17

Overview

U.S. metabolic health firm's Q1 revenue fell 34% yr/yr as active coach count declined

Company posted Q1 net loss of $2.1 mln, wider than prior year period

Medifast expects further coach declines and continued losses through 2026

Outlook

Company expects Q2 2026 revenue between $60 mln and $80 mln

Medifast sees Q2 2026 loss per share of $0.50 to $1.00

Company expects full-year 2026 revenue between $270 mln and $300 mln

Medifast sees 2026 loss per share of $1.55 to $2.75

Company expects number of active earning coaches to continue to decline in 2026

Result Drivers

COACH DECLINE - Revenue drop was primarily driven by a 45% decrease in active earning coaches, reflecting continued client acquisition challenges and increased use of GLP-1 weight loss drugs

HIGHER PRODUCTIVITY PER COACH - Revenue per active earning coach rose 19% as company prioritized productive coaches and efficient network structures

LOWER SALES VOLUME - Gross profit and margin declined due to lower sales volumes and loss of leverage on fixed costs

Company press release: ID:nBwC36jLa

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
$76.04 mln
Q1 EPS
-$0.19
Q1 Net Income
-$2.12 mln


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)